Page last updated: 2024-08-23

paclitaxel and Idiopathic Parkinson Disease

paclitaxel has been researched along with Idiopathic Parkinson Disease in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's4 (44.44)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amadeo, A; Calogero, AM; Cappelletti, G; Cartelli, D; Casagrande, FVM; Ciammola, A; Costa, I; De Gregorio, C; Gioria, M; Goldwurm, S; Hattori, N; Kuzumaki, N; Okano, H; Pezzoli, G; Roybon, L; Sassone, J1
Damascelli, B; Ticha, V1
Ahmed, N; Hegde, U; Jabbour, N; Usmani, S1
Cappelletti, G; Cartelli, D; Casagrande, F; Goldwurm, S; Pezzoli, G1
Feng, J; Ren, Y; Zhao, J1
Date, K; Egawa, M; Fujitoh, N; Fujiwara, H; Furukawa, M; Mizunoe, T; Sakashita, T; Ueda, K; Urabe, S; Urabe, T1
Feng, J; Jiang, H; Jiang, Q; Liu, W; Ren, Y1
Bower, JH; Muenter, MD1
Antman, K; Drazen, J; Lagakos, S1

Other Studies

9 other study(ies) available for paclitaxel and Idiopathic Parkinson Disease

ArticleYear
Parkin absence accelerates microtubule aging in dopaminergic neurons.
    Neurobiology of aging, 2018, Volume: 61

    Topics: Acetylation; Aging; Animals; Dopaminergic Neurons; Humans; Loss of Function Mutation; Mice, Knockout; Microtubules; Mitochondria; Paclitaxel; Parkinson Disease; PC12 Cells; Rats; Ubiquitin-Protein Ligases

2018
Successful intra-arterial chemotherapy for extramammary Paget's disease of the axilla in a patient with Parkinson's disease.
    Cardiovascular and interventional radiology, 2011, Volume: 34 Suppl 2

    Topics: Angiography; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Doxorubicin; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nanoparticles; Paclitaxel; Paget Disease, Extramammary; Parkinson Disease; Skin

2011
Acute psychosis after paclitaxel infusion.
    Connecticut medicine, 2011, Volume: 75, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Follow-Up Studies; Humans; Infusion Pumps; Laryngeal Neoplasms; Male; Paclitaxel; Parkinson Disease; Psychotic Disorders; Risk Factors

2011
Microtubule destabilization is shared by genetic and idiopathic Parkinson's disease patient fibroblasts.
    PloS one, 2012, Volume: 7, Issue:5

    Topics: Adult; Aged; Female; Fibroblasts; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Male; Microtubules; Middle Aged; Paclitaxel; Parkinson Disease; Phenotype; Phosphorylation

2012
Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003, Apr-15, Volume: 23, Issue:8

    Topics: Animals; Antibody Specificity; Cells, Cultured; Colchicine; Dimerization; Fibroblasts; Humans; Kidney; Ligases; Male; Mice; Microtubule-Associated Proteins; Microtubules; Mutation; Nerve Tissue Proteins; Neuroblastoma; Neurons; Paclitaxel; Parkinson Disease; Protein Binding; Rats; Rats, Sprague-Dawley; Tubulin; Ubiquitin-Protein Ligases; Ubiquitins

2003
[A case of ovarian cancer with Parkinson's disease treated by combined chemotherapy with paclitaxel and carboplatin followed by surgery].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:13

    Topics: Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; Antiparkinson Agents; Area Under Curve; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Hysterectomy; Middle Aged; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Parkinson Disease

2003
Selective vulnerability of dopaminergic neurons to microtubule depolymerization.
    The Journal of biological chemistry, 2005, Oct-07, Volume: 280, Issue:40

    Topics: Cell Death; Colchicine; Cytosol; Dopamine; Humans; Microtubules; Nerve Degeneration; Nocodazole; Oxidative Stress; Paclitaxel; Parkinson Disease; Polymers; Receptors, Dopamine; Rotenone; Substantia Nigra; Uncoupling Agents

2005
Temporary worsening of parkinsonism in a patient with Parkinson's disease after treatment with paclitaxel for a metastatic grade IV adenocarcinoma.
    Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:5

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Female; Humans; Infusions, Intravenous; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Unknown Primary; Paclitaxel; Parkinson Disease

1995
Designing and funding clinical trials of novel therapies.
    The New England journal of medicine, 2001, Mar-08, Volume: 344, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Bone Marrow Transplantation; Breast Neoplasms; Data Interpretation, Statistical; Female; Humans; Insurance, Health; Neurons; Paclitaxel; Parkinson Disease; Randomized Controlled Trials as Topic; Research Design; Research Support as Topic; Sample Size; Survival Analysis; Therapies, Investigational; United States

2001